Method of laser-induced tissue necrosis in carotenoid-containing skin structures

• US 5,304,170 A
• Filed: 03/12/1993
• Issued: 04/19/1994
• Est. Priority Date: 03/12/1993
• Status: Expired due to Fees

• Current Assignee: Howard A. Green
• Original Assignee: Howard A. Green
• Inventors: Green, Howard A.
• Primary Examiner(s): Pellegrino, Stephen C.
• Assistant Examiner(s): Harris, Sonya C.
• Application Number:
  US08/031,242
• Time in Patent Office: 403 Days
• Field of Search: 606/2, 606/3, 606/9, 606/13, 606/16, 128/898
• US Class Current: 606/9
• CPC Class Codes: A61B 18/203 applying laser energy to the outside of the body
• CPC Class Codes: A61B 2017/00761 Removing layer of skin tissue, e.g. wrinkles, scars or cancerous tissue
• CPC Class Codes: A61B 2017/22087 photodynamic
• CPC Class Codes: A61B 2018/00452 Skin

Abstract

A method for treating dermatological organ disorders and skin lesions in a mammal through the use of directed, pulsed laser light is described.

The dermatological disorders are characterized by an increase in concentration of potential photodynamic chemical compounds like carotenoid compounds, and especially the carotenoid beta-carotene, compared to normal skin. Pulsed dye laser light of a time and duration specific for maximal absorption by a carotenoid compound like beta-carotene is directed at the regions of carotenoid accumulation within a skin disorder. Thermal coagulation necrosis of the carotenoid-accumulating skin region results, though thermal damage to surrounding tissue is limited in amount.

Claims

1. A method for treating dermatological organ disorders and skin lesions in a mammal which method comprises:

a) identifying an area of skin within a region of mammalian skin, which area is characterized by cells of increased carotenoid compound concentration compared to the region of mammalian skin;

b) directing a pulsed laser light beam at said area of skin; and

c) exposing the said area of skin to said pulsed laser light beam of selected pulse duration and a wavelength of laser light between about 425 and 550 nanometers, and wherein the pulsed laser light beam contains radiant energy of between about 0.10 joules per square centimeter and 10 joules per square centimeter to cause thermal coagulation necrosis within the said cells of said area of skin and thereby to treat the dermatological organ disorder and skin lesion within said area of skin.

2. The method of claim 1 wherein the carotenoid compound is beta-carotene.

3. The method of claim 1 which includes increasing the concentration of the carotenoid compound by supplemental administration to the mammal of a pharmaceutically-acceptable form of said carotenoid compound prior to directing and exposing the said area to the light beam.

4. The method of claim 3 which includes increasing the concentration of the carotenoid compound in said cells through diet.

5. The method of claim 1 which includes directing the laser light beam to the area of skin by means of an optical fiber.

6. The method of claim 1 which includes pulsing the laser light beam between about 250 nanoseconds to 10 milliseconds.

7. The method of claim 1 wherein the laser light beam emanates from a pulsed dye laser.

8. The method of claim 1 wherein the pulsed laser light beam has a wavelength of about 504 nanometers.

9. The method of claim 1 which includes identifying when thermal coagulation necrosis occurs in said area of skin by a change in skin coloration in said area.

10. The method of claim 1 wherein the disorder and skin lesions are selected from this group consisting of eruptive, tuberous, tendenous, and plane xanthomas;

xanthelasmata;

xanthoma disseminatum;

juvenile xanthogranulomas;

nevus sebaceous;

sebaceous hyperplasia, adenoma, and carcinoma;

fordyces condition;

sebaceoma;

sebaceous glands;

acne vulgaris, conglobata, and rosacea; and

basal cell carcinoma with sebaceous differentiation.

11. The method of claim 1 wherein the said cells are sebaceous cells.

12. The method of claim 1 wherein the said cells are xanthomatous cells.

13. A method for treating dermatological skin disorders in a mammal which method comprises:

a) identifying an area of skin within a region of mammalian skin, which area is characterized by a concentration of a beta-carotene compound;

b) increasing the concentration of the beta-carotene compound within said area of skin by administration of a pharmaceutically-acceptable form of said carotene compound to the mammal;

c) directing a beam of pulsed laser light radiation having an energy of between about 0.10 and 10 joules per square centimeter and a wavelength of about 504 nanometers from a pulsed dye laser at said area of skin; and

d) exposing said area of skin to the beam of pulsed laser light radiation for a sufficient period of time to cause thermal coagulation necrosis within the area of skin and thereby to treat the skin disorder.